Cargando…
The gender-related variability in the pharmacokinetics and antiplasmodial activity of naphthoquine in rodents
BACKGROUND: Naphthoquine (NQ) is a suitable partner anti-malarial for the artemisinin-based combination therapy (ACT), which is recommended to be taken orally as a single-dose regimen. The metabolism of NQ was mainly mediated by CYP2D6, which is well-known to show gender-specific differences in its...
Autores principales: | Xie, Yuewu, Liu, Huixiang, Sun, Yanhong, Xing, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7020547/ https://www.ncbi.nlm.nih.gov/pubmed/32054478 http://dx.doi.org/10.1186/s12936-020-3153-8 |
Ejemplares similares
-
Population Pharmacokinetics of Antimalarial Naphthoquine in Combination with Artemisinin in Tanzanian Children and Adults: Dose Optimization
por: Ali, Ali Mohamed, et al.
Publicado: (2022) -
Artemisinin-Naphthoquine Combination (ARCO(®)): An Overview of the Progress
por: Hombhanje, Francis W., et al.
Publicado: (2010) -
Artemisinin‐naphthoquine for treating uncomplicated Plasmodium falciparum malaria
por: Isba, Rachel, et al.
Publicado: (2015) -
Naphthoquine: A Potent Broad-Spectrum Anti-Coronavirus Drug In Vitro
por: Song, Yabin, et al.
Publicado: (2022) -
Inhibitory effect of naphthoquine phosphate on Babesia gibsoni in vitro and Babesia rodhaini in vivo
por: Ji, Shengwei, et al.
Publicado: (2022)